Pacific Biosciences of California (PACB) financials · rev $160.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Pacific Biosciences of California (PACB) rev $160.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $160.0M | $154.0M |
| Cost of Revenue | $114.2M | $116.7M |
| Gross Profit | $45.8M | $37.3M |
| Operating Income | -$553.9M | -$474.3M |
| Net Income | -$546.4M | -$309.9M |
| EPS (Diluted) | -$1.82 | -$1.59 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $784.1M | $1.26B |
| Current Assets | $375.1M | $495.7M |
| Cash & Equivalents | $63.7M | $55.4M |
| Inventory | $49.3M | $58.8M |
| PP&E | $24.1M | $30.5M |
| Total Liabilities | $778.7M | $753.9M |
| Current Liabilities | $72.8M | $66.3M |
| Short-term Debt | N/A | N/A |
| Shareholders' Equity | $5.35M | $506.6M |
| Retained Earnings | -$2.70B | -$2.15B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$111.2M | -$206.1M |
| CapEx | $2.71M | $6.19M |
| Investing Cash Flow | $115.4M | $124.0M |
| Financing Cash Flow | $3.43M | -$43.0M |
| Net Change in Cash | $7.67M | -$125.0M |
| Free Cash Flow | -$113.9M | -$212.2M |
FAQ
What is PACB P/E and revenue?
Pacific Biosciences of California (PACB) rev $160.0M.
What is PACB revenue?
Pacific Biosciences of California last cached revenue is $160.0M (FY2025).
Is PACB profitable?
Pacific Biosciences of California last cached net income is -$546.4M (FY2025).
What are PACB total assets?
Pacific Biosciences of California last cached total assets are $784.1M (FY2025).
What is PACB free cash flow?
Pacific Biosciences of California last cached free cash flow is -$113.9M (FY2025).
Not investment advice. Cached statements, not a live tape.